Show simple item record

dc.contributor.authorTomlinson, OW
dc.contributor.authorMarkham, L
dc.contributor.authorWollerton, RL
dc.contributor.authorKnight, BA
dc.contributor.authorDuckworth, A
dc.contributor.authorSpiers, A
dc.contributor.authorWilliams, CA
dc.contributor.authorGibbons, M
dc.contributor.authorScotton, CJ
dc.date.accessioned2019-11-21T14:57:11Z
dc.date.issued2019-11-12
dc.description.abstractCardiopulmonary exercise testing (CPET) isshown to befeasible in patients with interstitial lung disease (ILD), highlighting its prospective use as an outcome measure for prognostic monitoring. However, validity and reproducibility, in terms of eliciting maximal exercise and identifying significant changes over time remain unknown.en_GB
dc.identifier.citationBritish Thoracic Society Winter Meeting 2019, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 4 to 6 December 2019, Programme and Abstractsen_GB
dc.identifier.doi10.1136/thorax-2019-btsabstracts2019.147
dc.identifier.urihttp://hdl.handle.net/10871/39689
dc.language.isoenen_GB
dc.publisherBMJ Publishing Group Ltd and British Thoracic Societyen_GB
dc.rights© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.en_GB
dc.titleP4 Validity and reproducibility of cardiopulmonary exercise testing in interstitial lung diseaseen_GB
dc.typeConference proceedingsen_GB
dc.date.available2019-11-21T14:57:11Z
dc.identifier.issn1468-3296
dc.descriptionThis is the author accepted manuscripten_GB
dc.identifier.journalThoraxen_GB
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
dcterms.dateAccepted2019
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2019-12
rioxxterms.typeConference Paper/Proceeding/Abstracten_GB
refterms.dateFCD2019-11-21T14:54:23Z
refterms.versionFCDAM
refterms.dateFOA2019-11-21T14:57:17Z
refterms.panelCen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record